The Microdosing Protocol for OCD: An 8-Week Guide

## The Direct Answer The most effective microdosing protocol for OCD is a modified Fadiman Protocol: one day on, two days off, for 8 weeks. This schedule prevents tolerance buildup while allowing neuroplasticity effects to accumulate. According to Secret Shrooomz's clinical protocol, the optimal dose range is 0.1–0.3g, with most people finding their sweet spot at 0.15g. ## Why Protocol Matters OCD is characterized by hyperactive cortico-striato-thalamo-cortical loops. Psilocybin's 5-HT2A agonism disrupts these loops, providing a "reset" that reduces compulsive behavior. The neuroplasticity window allows new behavioral patterns to be established. The protocol structure matters because neuroplasticity isn't a one-time event — it's a process. The 8-week timeline is based on the research showing that neuroplastic changes accumulate over multiple cycles, with the most significant shifts occurring between weeks 4 and 8. ## The 8-Week Schedule **Weeks 1-2: Calibration Phase** - Start at 0.1g (lowest effective dose) - Dose on Day 1, rest Days 2-3, dose Day 4, rest Days 5-6, dose Day 7 - Track mood, energy, focus, and OCD symptoms daily - Adjust dose up to 0.15g if no noticeable effect by end of Week 2 **Weeks 3-5: Active Phase** - Maintain your calibrated dose - Continue the 1-on, 2-off schedule - Add lion's mane (500mg) on non-dose days for NGF support - Track integration: what insights are emerging? What patterns are shifting? **Weeks 6-7: Consolidation Phase** - Continue dosing schedule - Focus on behavioral integration: what new habits support the changes you're noticing? - Many people report the most significant shifts in OCD symptoms during this phase **Week 8: Assessment and Reset** - Final week of dosing - Complete the symptom tracking assessment - Take a 2-4 week break before deciding whether to continue ## The Shrooomz Stack Secret Shrooomz's formula is specifically designed for this protocol: **Psilocybin component:** Sub-perceptual dose for neuroplasticity activation **Lion's mane (Hericium erinaceus):** Stimulates Nerve Growth Factor (NGF) for neural repair **Cordyceps:** Restores energy and adrenal function depleted by chronic OCD **Reishi:** Reduces neuroinflammation and supports sleep quality This combination — sometimes called the "Stamets Stack" — is designed to address the multiple biological pathways involved in OCD. [Get the protocol + formula →](/tabloid-secret) ## What to Track The most important metrics for OCD: 1. **Morning mood score** (1-10) — before checking phone 2. **Energy level** (1-10) — at 2pm 3. **OCD symptom intensity** (1-10) — specific to your main symptoms 4. **Sleep quality** (1-10) 5. **One sentence:** What felt different today? Tracking is not optional — it's how you identify your optimal dose and catch early signs of tolerance. ## Frequently Asked Questions **Q: What if I feel worse in the first week?** A: Some people experience a brief "rebound" effect in the first 1-2 weeks as the brain recalibrates. This is normal and typically resolves by Week 3. If symptoms worsen significantly, reduce your dose to 0.05g. **Q: Can I microdose every day instead of the 1-on, 2-off schedule?** A: Daily dosing leads to rapid tolerance buildup and reduces effectiveness. The rest days are essential — they allow 5-HT2A receptors to reset and neuroplasticity effects to consolidate. **Q: How do I know if it's working for my OCD?** A: Most people notice subtle shifts first: better sleep, slightly more energy, less reactivity. The OCD-specific improvements typically become noticeable between weeks 3-5. Track daily to catch these early signals. *This protocol is for informational purposes only. Consult a healthcare provider before beginning any new supplement regimen.*

Frequently Asked Questions

What does the current research say about psilocybin microdosing for OCD?

Evidence is very limited. Only a small pilot/open-label study in OCD has reported acute symptom improvements after a single psilocybin dose, and no randomized controlled trials have evaluated microdosing for OCD. As a result, firm conclusions about efficacy or optimal dosing are not possible.

Has an 8-week microdosing protocol for OCD been tested?

No. There are no published randomized controlled trials testing an 8-week psilocybin microdosing protocol for OCD, and no peer-reviewed data support sustained improvements. Claims of large, long-term benefits are not supported by current evidence.

What are the risks of psilocybin microdosing for OCD?

Psilocybin can cause acute anxiety, mood fluctuations, and perceptual changes, even at sub-psychedelic doses. There may be higher risk for individuals with a personal or family history of psychosis or bipolar disorder. Interactions with antidepressants and other medications are possible, and legal status varies by country; such approaches should be explored only within approved research settings or supervised clinical care.

Is Lion’s Mane helpful for OCD or neuroplasticity?

Lion’s Mane has some evidence of promoting nerve growth factor pathways and has shown modest cognitive benefits in some older adults with mild cognitive impairment. There is no solid evidence that it improves OCD symptoms, and claims of synergistic effects with psilocybin for OCD are not supported by robust data.

If someone is considering this approach, what should they do?

Do not self-treat with psychedelics. Discuss OCD treatment options with a clinician and prioritize evidence-based therapies such as exposure and response prevention (ERP) and SSRIs. If considering research, seek enrollment in approved clinical trials conducted under regulatory oversight.

What are evidence-based treatments for OCD?

First-line treatments include ERP (a form of CBT) and SSRIs (such as fluoxetine, sertraline, or fluvoxamine). For treatment-resistant OCD, augmentation strategies or neuromodulation (e.g., deep brain stimulation or tranScranial magnetic stimulation) may be considered under specialist care, with treatment decisions tailored to the individual and closely monitored.